Fundz

Gb Sciences Inc reported raising $25,000 in an initial SEC Form D filing, from an offering of $565,000

PRIVATEJun 03, 2022$25K of $565K raised

Amount Raised

$25,000

$25,000 sold, per SEC Form D (first sale Jun 3, 2022)

Round Type

Seed

Las VegasBiotechnology

Quick answer

GB SCIENCES raised $25,000 in a Seed round, dated June 3, 2022. GB SCIENCES is based in Las Vegas, Nevada, United States.

How much did GB SCIENCES raise?
GB SCIENCES raised $25,000 in a Seed round on June 3, 2022.
What does GB SCIENCES do?
GB Sciences, Inc. (OTCQB: GBLX) is a plant-inspired research and biopharmaceutical drug development company whose goal is to create patented formulations of plant-based, optimized therapeutic mixtures that target a..
Where is GB SCIENCES based and how big is it?
GB SCIENCES is based in Las Vegas, Nevada, United States.
Who are the decision-makers at GB SCIENCES?
Fundz holds 1 contact at GB SCIENCES. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as GB SCIENCES that raised within 45 days of this round, from Fundz verified event records.

  • i2O Therapeutics, Inc. raised $34M on July 18, 2022.
  • IMAGINE PHARMA LLC raised $50K (Seed) on July 18, 2022.
  • DELFI Diagnostics raised $225M (Series B) on July 18, 2022.
  • MatriSys Bioscience raised $8.4M on July 15, 2022.
  • Entero Therapeutics raised $300K (Seed) on July 15, 2022.
  • Gossamer Bio raised $120M on July 15, 2022.

Who to call at GB SCIENCES, and when

A new round usually means GB SCIENCES is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day GB SCIENCES raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at GB SCIENCES, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at GB SCIENCES. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

GB SCIENCES

Location

Las Vegas, Nevada, United States

About

GB Sciences, Inc. (OTCQB: GBLX) is a plant-inspired research and biopharmaceutical drug development company whose goal is to create patented formulations of plant-based, optimized therapeutic mixtures that target a variety of medical conditions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment GB SCIENCES raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts36 people are listed at GB SCIENCES. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for GB SCIENCES's next move

See what Strategic adds

GB SCIENCES raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.